China’s baby-formula revamp may boom Nestle, Danone

Bloomberg

A safety overhaul of China’s notorious baby-formula industry removed about 1,400 products from store shelves this week, clearing the way for international brands such as Nestle SA and Danone to grab greater shares of a $20 billion market. The regulations, effective from January 1, require factories making formula to register those products with China’s Food and Drug Administration (FDA) and pass safety inspections. Plants are limited to working with three brands, and those brands can make only three different products each.
Products not certified by the government were banned from sale. Those typically came from smaller, sometimes dubious local brands that used generic powder and put their own labels on it. With the new laws, they’ve been shoved out of factories in favour of multinational heavyweights with enough demand—and consumer trust—to keep manufacturing lines running at capacity.
“There are so many formulas for infant milk powder in the market,” said Liu Xuecong, secretary general of the government-supervised China Nutrition and Health Food Association. “Making formula is random and changes so frequently, and companies put forward so many concepts that consumers find it difficult to choose.”
China’s FDA has approved
940 infant-formula products from 129 factories so far, the agency said. That compares with more than 2,300 formulations available to parents before January 1.
The shakeup, in line with President Xi Jinping’s call to improve the quality of life for Chinese, has its roots in a 2008 scandal in which melamine-tainted milk and formula killed at least six infants and sickened tens of thousands more.
Even after a subsequent crackdown, scandals continued. In 2016, Shanghai police arrested nine people for producing and selling fake formula under the brand names Similac and Beingmate.
In November 2017, 18,000 cans of infant formula produced by Xinjiang Western Animal Husbandry were found to contain expired ingredients. Mothers paranoid about what they were feeding their babies turned to more-expensive foreign brands they assumed contain better ingredients and passed stricter safety checks. That vaulted Nestle, Danone and Reckitt Benckiser Group into the top spots in the $20 billion market, according to Euromonitor International. “If the quality is good, I’ll buy it, even if the price is high,” Zhou Liwen, a mother of a 3-year-old son, said in Shanghai. “I have never considered local-brand formula. Safety is the biggest problem.”
The government is trying to strengthen quality control by requiring factories to send formula samples to authorities such as the Chinese Academy of Inspection and Quarantine.
Foreign companies are positioning themselves to capitalise by
targeting parents in China’s secondary cities and countryside, where local brands typically dominated. One way is through the mother-baby retail chains, such as Babemax and Kidswant, spreading across the country. These types of stores emerged about a decade ago and now account for half of all formula sales.
Capturing those families will be crucial. With the relaxation of China’s one-child policy, Reckitt Benckiser anticipates about 20 million babies being born annually, which could trigger an annual growth rate of at least 7 percent in the infant-formula category during the next five years, said Patty O’Hayer, a spokeswoman.
The company bought Mead Johnson for $16.6 billion in 2017, and its Enfa and Enfinitas brands were approved for sale. Asia generated half of the Enfa lineup’s $3.7 billion in sales for 2016.
Nestle, the world’s biggest food company, is reassessing its sales strategy in China, said Binu Jacob, business executive officer overseeing the infant-nutrition business in the region. The Vevey, Switzerland-based company generated about
7 percent of its revenue in Greater China in 2016. Its best-selling baby-formula products in China include Illuma and S-26.